News
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Join us in Piccadilly Circus for free workshops and an exhibition featuring brain sculptures designed by world renowned artists.
An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
The new Chancellor, Jeremy Hunt, announced measures that will affect energy costs, household debt, and funding for health and social care services.
The 2022 Parkinson’s UK AGM took place on Saturday 15 October with members hearing about the last year at the charity.
17 to 23 October is Recycle Week 2022. We’re joining in and encouraging everyone to recycle for Parkinson’s UK.
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
An update on who we met at the Labour and Conservative party conferences